SI-APPX1.QXD
2/19/98 3:57 PM
Page 114
A APPENDIX A·1. Chemical Analytes and Hematologic Measurements Continued A·1.
Quantity Values in Healthy Persons in Traditional Units 0–40 (males), 0–80 (females) 2.75 ± 1.21 0.42 ± 0.54 0.3 ± 1.6 5.3 ± 1.2 ≤ 9.6 ng/mL (µg/L) < 4–6 74 ± 11 10–80 2.1 ± 0.4 6.5–10.5 40.8 ± 13.0 mean 0.45 1.0–5.4 0.6–1.2 1.5 ± 0.5 1.467 ± 0.220 1.49 ± 0.46 14–26 U/L mg/dL mg/L U/L ng/mL 1.00 1.00 U/L 16.667 mg/kg/d 7.626 mg/24 h 7.626 mg/24 h 7.626 Traditional Units Conversion Factor Values in Healthy Persons in SI Units SI Unit Significant Digits
Suggested Minimum Increment
Notes
creatine* (U) creatine* (U) creatine* (U) creatine kinase* (Amf) creatine kinase BB isoenzyme (CSF) creatine kinase MB isoenzyme (S) creatine kinase MB isoenzyme (S)
0–305 (males), µmol/d 0–610 (females) 21.0 ± 9.2 3.2 ± 4.1 5 ± 27 5.3 ± 1.2 ≤ 9.6 < 0.04–0.05 µmol/d µmol•kg–1•d–1 nkat/L µg/L µg/L
XXX XX.X XX.X XXX XX.X XX.X fraction of total activity 0.XX
5
0.1
0.1 1
At 40 weeks
0.1
0.1
% of total activity 0.01 0.0167 0.0167 88.402 8.840 µg/g hemoglobin 0.00884 mg/dL mg/L mg/dL mg/L g/d g/L mg/kg/d 88.402 8.840 88.402 8.840 8.840 8.840 8.840
0.01 1.23 ± 0.18 0.16–1.34 190 ± 35 57–93 0.36 ± 0.11 mean 40 9–48 50–110 13 ± 4 12.3 ± 1.8 13.2 ± 4.1 125–230 µkat/L µkat/L µmol/L µmol/L µmol/g hemoglobin µmol/L µmol/L µmol/L µmol/L mmol/d mmol/L µmol•kg–1•d–1 XX.X X.XX XXX XXX X.XX XXX XXX XX0 XXX XX.X XX.X XXX
114
creatine kinase MM isoenzyme (S) creatine kinase* (S) creatinine (Amf) creatinine (CSF) creatinine (Erc) creatinine (Erc) creatinine (Gastf) creatinine (P,S) creatinine (Swt) creatinine (U) creatinine (U) creatinine (U)
0.01
0.01 5 1
At 39–42 weeks
0.01 1 1
10 1
0.1
0.1 5